STEVEN GANNON - Director at Xenon Pharmaceuticals Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
XENE on Nasdaq
All Insider Reports
All Insider Reports

STEVEN GANNON - trading volume in the past year for Xenon Pharmaceuticals Inc.

Holdings reported by STEVEN GANNON for Xenon Pharmaceuticals Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 7,141 $217,657 $30.48 05 Jun 2025 Direct
Share Option (Right to Buy) 17,012 05 Jun 2025 Direct Common Shares
Restricted Share Units 2,645 05 Jun 2025 Direct Common Shares
Stock Option (Right to Buy) 0 14 May 2025 Direct Common Shares

Transactions reported by STEVEN GANNON for Xenon Pharmaceuticals Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.